Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment.
Ruppert
Anne-Marie
AM
Averous
Gerlinde
G
Stanciu
Daniela
D
Deroide
Nicolas
N
Riehm
Sophie
S
Poindron
Vincent
V
Pauli
Gabrielle
G
Debry
Christian
C
de Blay
Frédéric
F
D018927:Anti-Asthmatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy*; D015267:Churg-Strauss Syndrome / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab
D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab